I was not recorded because I was absent due to a prior family engagement. Had I been present, I would have voted YEA on Roll Call No. 10, NAY on Roll Call No. 11, and YEA on Roll Call No. 12. personal explanation Mrs. McCLAIN. Mr. Speaker, due to a death in the family, I needed to attend to the funeral proceedings and was unable to vote on the House floor. Had I been present, I would have voted YEA on Roll Call No. 10, passage of H.R. 153, NAY on Roll Call No. 11, MTR for H.R. 28, YEA on Roll Call No. 12, passage of H.R. 28. PERSONAL EXPLANATION
Share
More from Diana Harshbarger
The 340B program was created with good intentions to help vulnerable and underserved patients access care, but unfortunately, it has evolved into a massive, poorly supervised program with weak transparency and accountability safeguards.
I thank my colleague, Chairman Gus Bilirakis, who I affectionately call Gus, and Ranking Member Pallone for supporting this act. We have the opportunity today to vote on legislation centered around something that brings us all together…
Congress should bring transparency, competition, and accountability to this process so providers, innovators, and patients all benefit from a more open and competitive system.
As a pharmacist for more than 30 years, I’ve seen how government-protected monopolies can drive up costs, stifle innovation, and ultimately leave patients paying the price.





